Immunohistochemical Pitfalls and the Importance of Glypican-3 in the Diagnosis of Scirrhous Hepatocellular Carcinoma

被引：0
|
作者：
Krings, G.
Jain, D.
Wu, T-T
Yeh, M.
Torbenson, M.
Kakar, S.
机构：
[1] UCSF, San Francisco, CA USA
[2] Yale Univ, New Haven, CT USA
[3] Mayo Clin, Rochester, MN USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Johns Hopkins, Baltimore, MD USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1553
引用
收藏
页码：366A / 366A
页数：1
相关论文
共 50 条
  • [41] ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
    Kelada, O. J.
    Gutsche, N. T.
    Bell, M.
    Berman, R. M.
    Baidoo, K. E.
    Warner, B. M.
    Szajek, L. P.
    Hong, J.
    Ho, M.
    Choyke, P.
    Escorcia, F. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S180 - S181
  • [42] Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
    Zheng, Xiufeng
    Liu, Xun
    Lei, Yanna
    Wang, Gang
    Liu, Ming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
    Couzinet, Arnaud
    Suzuki, Toshihiro
    Nakatsura, Tetsuya
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (10) : 895 - 909
  • [44] Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
    Shirakawa, Hirofumi
    Suzuki, Hitomi
    Shimomura, Manami
    Kojima, Motohiro
    Gotohda, Naoto
    Takahashi, Shinichiro
    Nakagohri, Toshio
    Konishi, Masaru
    Kobayashi, Nobuaki
    Kinoshita, Taira
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2009, 100 (08): : 1403 - 1407
  • [45] A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
    Wu, Qunfeng
    Pi, Liya
    Thu Le Trinh
    Zuo, Chaohui
    Xia, Man
    Jiao, Yu
    Hou, Zhouhua
    Jo, Sung
    Puszyk, William
    Pham, Kien
    Nelson, David R.
    Robertson, Keith
    Ostrov, David
    Rameshwar, Pranela
    Xia, Chang Qing
    Liu, Chen
    MOLECULAR THERAPY, 2017, 25 (10) : 2299 - 2308
  • [46] Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
    Capurro, M
    Wanless, IR
    Sherman, M
    Deboer, G
    Shi, W
    Miyoshi, E
    Filmus, J
    GASTROENTEROLOGY, 2003, 125 (01) : 89 - 97
  • [47] Evaluation of the Glypican-3 Promoter for Transcriptional Targeting of Hepatocellular Carcinoma
    Dhungel, Bijay
    Jayachandran, Aparna
    Shrestha, Ritu
    Ramlogan-Steel, Charmaine
    Layton, Christopher J.
    Steel, Jason C.
    MOLECULAR THERAPY, 2017, 25 (05) : 68 - 68
  • [48] Identification of nanobodies against hepatocellular carcinoma marker glypican-3
    Wang, Wenyi
    Xu, Chang
    Wang, Huanan
    Jiang, Changan
    MOLECULAR IMMUNOLOGY, 2021, 131 : 13 - 22
  • [49] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
    Yukihiro Haruyama
    Hiroaki Kataoka
    World Journal of Gastroenterology, 2016, (01) : 275 - 283
  • [50] The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma
    Orrock, J. M.
    Mounajjed, T.
    Zhang, L.
    Wu, T-T
    LABORATORY INVESTIGATION, 2012, 92 : 421A - 421A
12345